JP2020523370A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020523370A5 JP2020523370A5 JP2019569215A JP2019569215A JP2020523370A5 JP 2020523370 A5 JP2020523370 A5 JP 2020523370A5 JP 2019569215 A JP2019569215 A JP 2019569215A JP 2019569215 A JP2019569215 A JP 2019569215A JP 2020523370 A5 JP2020523370 A5 JP 2020523370A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- nutritional supplement
- selenium
- fish oil
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023108547A JP2023115357A (ja) | 2017-06-13 | 2023-06-30 | 癌化学療法を増強するための組成物および方法 |
| JP2025235858A JP2026026381A (ja) | 2017-06-13 | 2025-12-05 | 癌化学療法を増強するための組成物および方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762519093P | 2017-06-13 | 2017-06-13 | |
| US201762519096P | 2017-06-13 | 2017-06-13 | |
| US62/519,096 | 2017-06-13 | ||
| US62/519,093 | 2017-06-13 | ||
| US201762595002P | 2017-12-05 | 2017-12-05 | |
| US62/595,002 | 2017-12-05 | ||
| US201862670275P | 2018-05-11 | 2018-05-11 | |
| US62/670,275 | 2018-05-11 | ||
| PCT/US2018/037274 WO2018231943A2 (en) | 2017-06-13 | 2018-06-13 | Compositions and methods for enhancing cancer chemotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023108547A Division JP2023115357A (ja) | 2017-06-13 | 2023-06-30 | 癌化学療法を増強するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020523370A JP2020523370A (ja) | 2020-08-06 |
| JP2020523370A5 true JP2020523370A5 (https=) | 2021-07-26 |
| JP7788129B2 JP7788129B2 (ja) | 2025-12-18 |
Family
ID=64658652
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019569215A Active JP7788129B2 (ja) | 2017-06-13 | 2018-06-13 | 癌化学療法を増強するための組成物および方法 |
| JP2023108547A Pending JP2023115357A (ja) | 2017-06-13 | 2023-06-30 | 癌化学療法を増強するための組成物および方法 |
| JP2025235858A Pending JP2026026381A (ja) | 2017-06-13 | 2025-12-05 | 癌化学療法を増強するための組成物および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023108547A Pending JP2023115357A (ja) | 2017-06-13 | 2023-06-30 | 癌化学療法を増強するための組成物および方法 |
| JP2025235858A Pending JP2026026381A (ja) | 2017-06-13 | 2025-12-05 | 癌化学療法を増強するための組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10905725B2 (https=) |
| EP (1) | EP3638247A4 (https=) |
| JP (3) | JP7788129B2 (https=) |
| KR (2) | KR20240171182A (https=) |
| CN (1) | CN111556754A (https=) |
| CA (1) | CA3066713A1 (https=) |
| IL (1) | IL271328A (https=) |
| TW (2) | TW201906633A (https=) |
| WO (1) | WO2018231943A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7123945B2 (ja) | 2016-10-03 | 2022-08-23 | シャー，ホウン・サイモン | がん放射線療法を増強するための組成物および方法 |
| JP7788129B2 (ja) | 2017-06-13 | 2025-12-18 | シャー，ホウン・サイモン | 癌化学療法を増強するための組成物および方法 |
| US10905724B2 (en) | 2017-06-13 | 2021-02-02 | Houn Simon Hsia | Compositions and methods for enhancing hyperthermia therapy |
| US12029765B2 (en) | 2017-06-13 | 2024-07-09 | Houn Simon Hsia | Compositions and methods for treating cancer |
| JP7336993B2 (ja) | 2017-06-13 | 2023-09-01 | シャー，ホウン・サイモン | 癌放射線療法を増強する組成物および方法 |
| WO2020205885A1 (en) * | 2019-04-01 | 2020-10-08 | Houn Simon Hsia | Compositions and methods for cancer immunotherapy |
| WO2022035869A1 (en) * | 2020-08-10 | 2022-02-17 | Houn Simon Hsia | Compositions and methods for treating viral infection |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4348483A (en) | 1981-01-23 | 1982-09-07 | Universal Foods Corporation | Method for the production of chromium yeast |
| US4569836A (en) | 1981-08-27 | 1986-02-11 | Gordon Robert T | Cancer treatment by intracellular hyperthermia |
| CA2010511A1 (en) | 1989-03-01 | 1990-09-01 | Roberto L. Ceriani | Method of enhancing cancer therapy by administration of unsaturated fatty acids |
| NZ248605A (en) | 1993-05-28 | 1994-12-22 | Abbott Lab | Enteral nutritional product comprising protein and fat |
| US20020010144A1 (en) | 1994-04-29 | 2002-01-24 | Robert Sobol | Enhancing the sensitivity of tumor cells to therapies |
| US5976548A (en) | 1994-11-08 | 1999-11-02 | Viva America Marketing, Inc. | Nutritional supplement composition and use |
| US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
| US6440464B1 (en) | 1996-06-10 | 2002-08-27 | Viva Life Science | Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates |
| US6197295B1 (en) * | 1996-09-25 | 2001-03-06 | Viva America Marketing Corporation | Dietary supplementation with, and methods for administration of yeast-derived selenium product |
| US5810888A (en) | 1997-06-26 | 1998-09-22 | Massachusetts Institute Of Technology | Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery |
| CA2339473A1 (en) | 1998-08-04 | 2000-02-17 | John V. Kosbab | Nutrient and therapeutic compositions for the treatment of cancer |
| US7569551B2 (en) | 2000-02-25 | 2009-08-04 | The University Of British Columbia | Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides |
| EP1383573A4 (en) | 2001-03-26 | 2005-09-14 | Ellen A Inc | METHOD AND DEVICE FOR THE TREATMENT OF ANGRYED TISSUE |
| EP1438971A4 (en) | 2001-10-25 | 2005-01-12 | Ttc Co Ltd | IMMUNE AMPLIFIERS IN THERAPEUTIC THERAPY IN CANCER |
| KR20040073559A (ko) | 2002-01-11 | 2004-08-19 | 라쓰 마티아스 | 폴리페놀을 포함하는 영양성 제약 제제 및 암 치료에서의용도 |
| US20040087490A1 (en) | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
| AU2002951833A0 (en) | 2002-10-02 | 2002-10-24 | Novogen Research Pty Ltd | Compositions and therapeutic methods invloving platinum complexes |
| US7744930B2 (en) | 2002-11-22 | 2010-06-29 | Shaklee Corporation | Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass |
| US8663679B2 (en) | 2004-04-29 | 2014-03-04 | Abbott Laboratories | Compositions for improving breast health in women |
| US9107864B2 (en) | 2004-06-07 | 2015-08-18 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to treat cancers |
| US20060088574A1 (en) | 2004-10-25 | 2006-04-27 | Manning Paul B | Nutritional supplements |
| US20070116802A1 (en) | 2005-11-23 | 2007-05-24 | Carl Germano | High quality caloric composition |
| US8017147B2 (en) | 2008-04-07 | 2011-09-13 | Mazed Mohammad A | Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance |
| US20090110674A1 (en) | 2007-10-24 | 2009-04-30 | Loizou Nicos C | Health supplement |
| WO2009157759A1 (en) | 2008-06-23 | 2009-12-30 | N.V. Nutricia | Nutritional composition for improving the mammalian immune system |
| RU2011115184A (ru) | 2008-09-19 | 2012-10-27 | Нестек С.А. (Ch) | Питательная поддержка для предупреждения или ослабления паралича костного мозга или нейтропении во время противораковой терапии |
| US8257694B2 (en) | 2009-05-14 | 2012-09-04 | Product Partners, Llc | Nutritional compositions for reducing oxidative damage |
| CA2763041C (en) | 2009-05-29 | 2018-11-27 | Robert A. Newman | Compositions and methods for modulating lipid composition |
| KR101275724B1 (ko) | 2009-12-09 | 2013-06-17 | 한국전자통신연구원 | 단일 기판 집적 회로 장치 및 그 제조 방법 |
| WO2011094579A2 (en) | 2010-01-29 | 2011-08-04 | New Chapter Inc. | Mushroom compositions and methods for making and using |
| JP5882889B2 (ja) * | 2010-03-15 | 2016-03-09 | 国立大学法人 岡山大学 | 抗腫瘍剤 |
| US20120010688A1 (en) | 2010-07-09 | 2012-01-12 | Lamb Karl J | Implantable conductive element and method of use inhyperthermic treatment |
| US9669053B2 (en) | 2010-07-26 | 2017-06-06 | Chemotherapeutics, Llc | Compositions and methods for enhancing the effectiveness of systemic, HIPEC, IP, and related cancer treatments |
| WO2012122295A2 (en) * | 2011-03-07 | 2012-09-13 | Ned Biosystems, Inc. | Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin |
| KR101868675B1 (ko) | 2012-10-05 | 2018-06-18 | 연세대학교 산학협력단 | 민감화 물질을 포함하는 온열 치료용 조성물 |
| US9072768B2 (en) | 2013-01-22 | 2015-07-07 | Kibow Biotech, Inc. | Composition and method for increasing effectiveness of radiation or chemotherapy |
| US9107947B2 (en) | 2013-01-31 | 2015-08-18 | The Penn State Research Foundation | Anti-cancer compositions and methods |
| WO2014159851A2 (en) | 2013-03-13 | 2014-10-02 | The Board Of Regents Of The University Of Texas System | Novel low density lipoprotein nanocarriers for targeted delevery of omega-3 polyunsaturated fatty acids to cancer |
| US20140294795A1 (en) * | 2013-03-28 | 2014-10-02 | Houn Simon Hsia | Nutritional Composition |
| US9877944B2 (en) | 2013-04-22 | 2018-01-30 | Smartfish As | Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer |
| CN105705037A (zh) | 2013-07-31 | 2016-06-22 | 株式会社明治 | 用于抑制肿瘤生长的营养组合物 |
| EP3033091B1 (en) | 2013-08-16 | 2022-09-07 | Versitech Limited | Probiotic composition and use thereof in the prevention and treatment of hepatocellular carcinoma |
| US20170246136A1 (en) | 2014-09-24 | 2017-08-31 | OliVentures, Inc. | Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases |
| CN105641000A (zh) | 2015-06-01 | 2016-06-08 | 深圳市康道生物有限公司 | 一种含灰树花提取物的抗肿瘤组合物及其制备方法 |
| AU2016357227A1 (en) | 2015-11-18 | 2018-05-31 | Seiberg Consulting, LLC | Compositions containing natural extracts and use thereof for skin and hair |
| CN105617358A (zh) * | 2015-12-29 | 2016-06-01 | 广州市戴菊科技发展有限公司 | 一种具有抗肿瘤功能的医用食品及其制备方法 |
| JP6376186B2 (ja) | 2016-08-04 | 2018-08-22 | トヨタ自動車株式会社 | サスペンションメンバ |
| JP7123945B2 (ja) | 2016-10-03 | 2022-08-23 | シャー，ホウン・サイモン | がん放射線療法を増強するための組成物および方法 |
| CN106822560A (zh) | 2017-04-07 | 2017-06-13 | 湖北工程学院 | 药物组合物及其制备方法 |
| JP7788129B2 (ja) | 2017-06-13 | 2025-12-18 | シャー，ホウン・サイモン | 癌化学療法を増強するための組成物および方法 |
| JP7336993B2 (ja) | 2017-06-13 | 2023-09-01 | シャー，ホウン・サイモン | 癌放射線療法を増強する組成物および方法 |
-
2018
- 2018-06-13 JP JP2019569215A patent/JP7788129B2/ja active Active
- 2018-06-13 CN CN201880052093.9A patent/CN111556754A/zh active Pending
- 2018-06-13 EP EP18817307.4A patent/EP3638247A4/en active Pending
- 2018-06-13 KR KR1020247039365A patent/KR20240171182A/ko active Pending
- 2018-06-13 WO PCT/US2018/037274 patent/WO2018231943A2/en not_active Ceased
- 2018-06-13 CA CA3066713A patent/CA3066713A1/en active Pending
- 2018-06-13 US US16/007,539 patent/US10905725B2/en active Active
- 2018-06-13 TW TW107120419A patent/TW201906633A/zh unknown
- 2018-06-13 KR KR1020207000865A patent/KR102736425B1/ko active Active
- 2018-06-13 TW TW114100270A patent/TW202535473A/zh unknown
-
2019
- 2019-12-11 IL IL271328A patent/IL271328A/en unknown
-
2021
- 2021-02-01 US US17/163,793 patent/US12036246B2/en active Active
-
2023
- 2023-06-30 JP JP2023108547A patent/JP2023115357A/ja active Pending
-
2025
- 2025-12-05 JP JP2025235858A patent/JP2026026381A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020523370A5 (https=) | ||
| Heffeter et al. | The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo | |
| Fazio et al. | Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): a critical view | |
| Ghoneum et al. | Modified arabinoxylan from rice bran, MGN-3/biobran, sensitizes metastatic breast cancer cells to paclitaxel in vitro | |
| Chen et al. | Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancer | |
| Momeni et al. | Effect of silymarin in the prevention of cisplatin nephrotoxicity, a clinical trial study | |
| Calvaruso et al. | Cannabinoid-associated cell death mechanisms in tumor models | |
| Athira et al. | Flavonoids, the emerging dietary supplement against cisplatin-induced nephrotoxicity | |
| Ikehata et al. | Different effects of epigenetic modifiers on the cytotoxicity induced by 5-fluorouracil, irinotecan or oxaliplatin in colon cancer cells | |
| WO2012122295A2 (en) | Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin | |
| Sreenivasan et al. | Synergistic effect of curcumin in combination with anticancer agents in human retinoblastoma cancer cell lines | |
| Fakih et al. | Selenium protects against toxicity induced by anticancer drugs and augments antitumor activity: a highly selective, new, and novel approach for the treatment of solid tumors | |
| Jafarzadeh et al. | Combined regimens of cisplatin and metformin in cancer therapy: A systematic review and meta-analysis | |
| JP2019536767A (ja) | エピカテキン及び抗癌化合物の組合せを含む組成物 | |
| RU2010143893A (ru) | Способ и композиции для лечения рака | |
| JP2011515481A5 (https=) | ||
| Johnson et al. | Luteolin and gemcitabine protect against pancreatic cancer in an orthotopic mouse model | |
| WO2018231943A3 (en) | COMPOSITIONS AND METHODS FOR IMPROVING CHEMOTHERAPY TREATMENT OF CANCER | |
| Raina et al. | Molecular insight into apoptosis mediated by flavones in cancer | |
| JP2020523375A5 (https=) | ||
| Chhabra et al. | Silibinin: A promising anti-neoplastic agent for the future? A critical reappraisal | |
| Kawasaki et al. | Therapeutic potential of garlic, aged garlic extract and garlic‑derived compounds on pancreatic cancer | |
| Taghvaei et al. | Carboplatin and epigallocatechin-3-gallate synergistically induce cytotoxic effects in esophageal cancer cells | |
| Mihlon et al. | Chemotherapy agents: a primer for the interventional radiologist | |
| Michael et al. | 13-cis-Retinoic acid in combination with gemcitabine in the treatment of locally advanced and metastatic pancreatic cancer—report of a pilot phase II study |